RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 119 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $116,000 | -41.7% | 21,047 | +1.8% | 0.00% | – |
| Q4 2021 | $199,000 | -56.3% | 20,670 | -18.9% | 0.00% | – |
| Q3 2021 | $455,000 | -14.2% | 25,477 | +17.5% | 0.00% | – |
| Q2 2021 | $530,000 | +109.5% | 21,686 | +126.8% | 0.00% | – |
| Q1 2021 | $253,000 | +29.7% | 9,561 | -62.8% | 0.00% | – |
| Q4 2020 | $195,000 | +91.2% | 25,711 | +25.3% | 0.00% | – |
| Q3 2020 | $102,000 | -19.0% | 20,519 | -2.4% | 0.00% | – |
| Q2 2020 | $126,000 | +22.3% | 21,020 | -9.3% | 0.00% | – |
| Q1 2020 | $103,000 | -97.1% | 23,168 | -93.9% | 0.00% | -100.0% |
| Q4 2019 | $3,602,000 | +21.0% | 379,206 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,977,000 | -50.1% | 379,206 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $5,965,000 | -13.1% | 379,206 | +0.0% | 0.00% | 0.0% |
| Q1 2019 | $6,863,000 | +12.5% | 379,181 | -0.1% | 0.00% | 0.0% |
| Q4 2018 | $6,102,000 | -33.4% | 379,505 | -0.6% | 0.00% | -33.3% |
| Q3 2018 | $9,166,000 | – | 381,902 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |